These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients. Davatchi F; Nikbin B; Shams H; Sadeghi Abdollahi B; Mohyeddin M; Shahram F Int J Rheum Dis; 2013 Apr; 16(2):139-47. PubMed ID: 23773637 [TBL] [Abstract][Full Text] [Related]
49. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420 [TBL] [Abstract][Full Text] [Related]
50. Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy. Yang P; Huang G; Du L; Ye Z; Hu K; Wang C; Qi J; Liang L; Wu L; Cao Q; Kijlstra A Ocul Immunol Inflamm; 2019; 27(1):7-14. PubMed ID: 29040035 [TBL] [Abstract][Full Text] [Related]
51. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial. Demiroglu H; Ozcebe OI; Barista I; Dündar S; Eldem B Lancet; 2000 Feb; 355(9204):605-9. PubMed ID: 10696980 [TBL] [Abstract][Full Text] [Related]
52. Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients. Lee JH; Lee CS; Lee SC BMC Ophthalmol; 2018 Feb; 18(1):52. PubMed ID: 29463220 [TBL] [Abstract][Full Text] [Related]
53. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study. Interlandi E; Leccese P; Olivieri I; Latanza L Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224 [TBL] [Abstract][Full Text] [Related]
54. Results of interferon-alfa therapy in patients with Behçet uveitis. Tugal-Tutkun I; Güney-Tefekli E; Urgancioglu M Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1692-5. PubMed ID: 16673135 [TBL] [Abstract][Full Text] [Related]
55. Interferon therapy for Behçet's disease. Alpsoy E; Yilmaz E; Başaran E J Am Acad Dermatol; 1994 Oct; 31(4):617-9. PubMed ID: 8089288 [TBL] [Abstract][Full Text] [Related]
56. Long-term effects of interferon alpha 2A treatment in Behçet's disease. Boyvat A; Sişman-Solak C; Gürler A Dermatology; 2000; 201(1):40-3. PubMed ID: 10971058 [TBL] [Abstract][Full Text] [Related]
57. Spectrum of Behçet's disease in the Indian population. Sachdev N; Kapali N; Singh R; Gupta V; Gupta A Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879 [TBL] [Abstract][Full Text] [Related]